Guardian Pharmacy Services, Inc.
GRDN · Consumer Discretionary · FY2025 filings · Shallow moat ·
Doesn't clear the bar
The five investor questions
Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend.
Median gross margin 20.0% over 2y, very stable.
Median ROIC -1.2%, above the 12% hurdle in 50% of years.
Net cash position — no leverage risk.
Owner earnings trend unclear, share count n/a.
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
Price vs. owner-earnings value range
- Owner earnings (normalized)
- —
- Value range / share
- —
- Conservative high estimate / share
- —
- Recent price
- $39.78
- Price vs. high estimate
- No price data
Conservative range under moat-index@2.0.0: low end 11.1×, high end capped at 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.
3 years of fundamentals
The business, in plain English
Guardian Pharmacy Services, Inc. booked $1.4B of revenue in FY2025 in the Consumer Discretionary sector and kept 20.2% of it as gross profit — a moderate-margin business by that measure. After every other cost, 3.4% of each revenue dollar reached the bottom line.
The balance sheet carried $0 of total debt in FY2025 against $58.1M of owner earnings — roughly 0.0 years of owner earnings to retire it all. Balance-Sheet Safety scores it 100/100.
This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.
Gaps in a line mean that item isn’t in GRDN’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.
Moat Score history
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
- Methodology upgraded moat-index@1.2.0tomoat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Track record
How Guardian Pharmacy Services, Inc.’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.
How to read this: each dot is what the engine would have scored GRDN on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.
Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The indexed price path isn't available for this company yet; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.
What followed, in the years it rated Wide
In the reconstructed history shown, GRDN did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.
Consumer Discretionary context
#220 of 482 scored Consumer Discretionary companies, ranked by Moat Score.
Nearest peers by Moat Score
- #218SPWH SPORTSMAN’S WAREHOUSE HOLDINGS, INC.49.8 out of 100, Shallow moatShallow moat
- #219LINC LINCOLN EDUCATIONAL SERVICES CORPORATION49.8 out of 100, Shallow moatShallow moat
- #221TSLA Tesla, Inc.49.7 out of 100, Shallow moatShallow moat
- #222IQV IQVIA HOLDINGS INC.49.7 out of 100, Shallow moatShallow moat
Compare GRDN with its nearest peers →All Consumer Discretionary companies on the Index →
Common questions about GRDN
- Does Guardian Pharmacy Services, Inc. have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores Guardian Pharmacy Services, Inc. (GRDN) 49.8 out of 100 — a Shallow moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend not measurable from the filings, pricing power 38, returns on capital 18, balance-sheet safety 100, capital discipline 44.
- How has GRDN's Moat Score changed over time?
- The record logs 5 readings since Jul 18, 2026; the latest reads 49.8 out of 100 (shallow moat). No tier changes on record yet. (A methodology upgrade on Jul 20, 2026 re-based the score; readings across engine versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.